BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1478770)

  • 1. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
    Pasricha JS; Das SS
    Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
    Pasricha JS;
    Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
    Pasricha JS; Khaitan BK; Raman RS; Chandra M
    Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kaur S; Kanwar AJ
    Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus.
    Pasricha JS; Thanzama J; Khan UK
    Br J Dermatol; 1988 Jul; 119(1):73-7. PubMed ID: 3408666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
    Jain R; Kumar B
    J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
    Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
    J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative treatment for pemphigus.
    Pasricha JS; Khaitan BK
    Arch Dermatol; 1996 Dec; 132(12):1518-9. PubMed ID: 8961890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
    Kandan S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
    Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
    Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
    Sethy PK; Khandpur S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.